These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2651162)
1. Putative precursors of endothelin have less vasoconstrictor activity in vitro but a potent pressor effect in vivo. Kashiwabara T; Inagaki Y; Ohta H; Iwamatsu A; Nomizu M; Morita A; Nishikori K FEBS Lett; 1989 Apr; 247(1):73-6. PubMed ID: 2651162 [TBL] [Abstract][Full Text] [Related]
2. Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro. McMahon EG; Palomo MA; Moore WM; McDonald JF; Stern MK Proc Natl Acad Sci U S A; 1991 Feb; 88(3):703-7. PubMed ID: 1992461 [TBL] [Abstract][Full Text] [Related]
3. Endothelium-dependent mesenteric vasorelaxant effects and systemic actions of endothelin (16-21) and other endothelin-related peptides in the rat. Douglas SA; Hiley CR Br J Pharmacol; 1991 Oct; 104(2):311-20. PubMed ID: 1797300 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of biological actions of big endothelin-1 by phosphoramidon. Fukuroda T; Noguchi K; Tsuchida S; Nishikibe M; Ikemoto F; Okada K; Yano M Biochem Biophys Res Commun; 1990 Oct; 172(2):390-5. PubMed ID: 2241940 [TBL] [Abstract][Full Text] [Related]
5. Endothelium-dependent vascular activities of endothelin-like peptides in the isolated superior mesenteric arterial bed of the rat. Douglas SA; Hiley CR Br J Pharmacol; 1990 Sep; 101(1):81-8. PubMed ID: 2282471 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties of endothelins and big endothelins in ketamine/xylazine or urethane anesthetized rats. Gratton JP; Maurice MC; Rae GA; D'Orléans-Juste P Am J Hypertens; 1995 Nov; 8(11):1121-7. PubMed ID: 8554736 [TBL] [Abstract][Full Text] [Related]
7. The pharmacological properties of the peptide, endothelin. Eglen RM; Michel AD; Sharif NA; Swank SR; Whiting RL Br J Pharmacol; 1989 Aug; 97(4):1297-307. PubMed ID: 2551446 [TBL] [Abstract][Full Text] [Related]
8. Endothelin causes contraction of canine and bovine arterial smooth muscle in vitro and in vivo. Suzuki Y; Satoh S; Ikegaki I; Asano T; Shibuya M; Sugita K; Lederis K; Rorstad O Acta Neurochir (Wien); 1990; 104(1-2):42-7. PubMed ID: 2201171 [TBL] [Abstract][Full Text] [Related]
9. Evidence for phosphoramidon-sensitive conversion of big endothelin-1 to endothelin-1 in isolated rat mesenteric artery. Hisaki K; Matsumura Y; Ikegawa R; Nishiguchi S; Hayashi K; Takaoka M; Morimoto S Biochem Biophys Res Commun; 1991 Jun; 177(3):1127-32. PubMed ID: 2059203 [TBL] [Abstract][Full Text] [Related]
10. Effects of pre-contraction with endothelin-1 on alpha 2-adrenoceptor- and (endothelium-dependent) neuropeptide Y-mediated contractions in the isolated vascular bed of the rat tail. MacLean MR; McGrath JC Br J Pharmacol; 1990 Sep; 101(1):205-11. PubMed ID: 2178016 [TBL] [Abstract][Full Text] [Related]
11. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065. Warner TD; Allcock GH; Vane JR Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats. Le Monnier de Gouville AC; Mondot S; Lippton H; Hyman A; Cavero I J Pharmacol Exp Ther; 1990 Jan; 252(1):300-11. PubMed ID: 2405151 [TBL] [Abstract][Full Text] [Related]
13. Cross tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin. Le Monnier de Gouville AC; Cavero I Br J Pharmacol; 1991 Sep; 104(1):77-84. PubMed ID: 1786522 [TBL] [Abstract][Full Text] [Related]
14. Systemic hemodynamic effects of endothelin in rats. King AJ; Pfeffer JM; Pfeffer MA; Brenner BM Am J Physiol; 1990 Mar; 258(3 Pt 2):H787-92. PubMed ID: 2180322 [TBL] [Abstract][Full Text] [Related]
15. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney. Wellings RP; Corder R; Warner TD; Cristol JP; Thiemermann C; Vane JR Br J Pharmacol; 1994 Feb; 111(2):515-20. PubMed ID: 8004396 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of intrathecally administered endothelins and big endothelin-1 in conscious rats: receptor characterization and mechanism of action. Poulat P; D'Orléans-Juste P; de Champlain J; Yano M; Couture R Brain Res; 1994 Jun; 648(2):239-48. PubMed ID: 7522926 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of nifedipine to prevent systemic and renal vasoconstrictor effects of endothelin. Madeddu P; Yang XP; Anania V; Troffa C; Pazzola A; Soro A; Manunta P; Tonolo G; Demontis MP; Varoni MV Am J Physiol; 1990 Aug; 259(2 Pt 2):F304-11. PubMed ID: 2201205 [TBL] [Abstract][Full Text] [Related]
18. Mass analysis of 1,2-diacylglycerol in cultured rabbit vascular smooth muscle cells. Comparison of stimulation by angiotensin II and endothelin. Sunako M; Kawahara Y; Hirata K; Tsuda T; Yokoyama M; Fukuzaki H; Takai Y Hypertension; 1990 Jan; 15(1):84-8. PubMed ID: 2403981 [TBL] [Abstract][Full Text] [Related]
19. Homologous desensitization of the effects of endothelin on rabbit aorta rings and on cultured rat aorta smooth muscle cells. Miasiro N; Paiva AC Eur J Pharmacol; 1990 Apr; 179(1-2):151-8. PubMed ID: 2194820 [TBL] [Abstract][Full Text] [Related]
20. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. Warner TD; Allcock GH; Corder R; Vane JR Br J Pharmacol; 1993 Oct; 110(2):777-82. PubMed ID: 8242251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]